Company / EPS (Diluted)
Equillium, Inc. EPS (Diluted) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.23
FY2025
5-year range
-$1.85 / -$0.23
FY2022-FY2025
Trend
+39.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.85 to $-0.23 over the past 2 years.
Based on SEC 10-K filings.
-0.23 in FY2025.
Improved from $-1.85 to $-0.23 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 39.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.23 | +39.5% |
| FY2024 | -$0.38 | +79.5% |
| FY2023 | -$1.85 | -36.0% |
| FY2022 | -$1.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026